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Klebsiella pneumoniae is at the forefront of antimicrobial resistance for Gram-negative pathogenic bacteria, as strains resistant
to third-generation cephalosporins and carbapenems are widely reported. The worldwide diffusion of these strains is of great
concern due to the high morbidity and mortality often associated with K. pneumoniae infections in nosocomial environments.
We sequenced the genomes of 89 K. pneumoniae strains isolated in six Italian hospitals. Strains were selected based on antibio-
types, regardless of multilocus sequence type, to obtain a picture of the epidemiology of K. pneumoniae in Italy. Thirty-one
strains were carbapenem-resistant K. pneumoniae carbapenemase producers, 29 were resistant to third-generation cephalospo-
rins, and 29 were susceptible to the aforementioned antibiotics. The genomes were compared to all of the sequences available in
the databases, obtaining a data set of 319 genomes spanning the known diversity of K. pneumoniaeworldwide. Bioinformatic
analyses of this global data set allowed us to construct a whole-species phylogeny, to detect patterns of antibiotic resistance dis-
tribution, and to date the differentiation between specific clades of interest. Finally, we detected an1.3-Mb recombination that
characterizes all of the isolates of clonal complex 258, the most widespread carbapenem-resistant group of K. pneumoniae. The
evolution of this complex was modeled, dating the newly detected and the previously reported recombination events. The pres-
ent study contributes to the understanding of K. pneumoniae evolution, providing novel insights into its global genomic charac-
teristics and drawing a dated epidemiological scenario for this pathogen in Italy.
Multidrug resistance is currently a matter of concern world-wide. At the end of the 1970s,most Escherichia coli andKleb-
siella pneumoniae strains encoded ampicillin-hydrolyzing -lacta-
mases,making itnecessary touse third-generationcephalosporins. In
the early 1980s, the first cases of resistance to these novel antibiotics
were reported in Enterobacteriaceae (1) and were caused by genes
classified as ESBL (extended-spectrum beta-lactamases). In 1985,
the United States Food and Drug Administration approved the
commercialization of imipenem, a molecule that showed activity
against ESBL producers. This drug, and similar compounds that
quickly followed (i.e., carbapenems), then were introduced into
clinical practice and widely used.
In 2001, Yigit and colleagues reported a K. pneumoniae strain
isolated in 1996 that exhibited resistance to the carbapenems imi-
penem and meropenem (2). The gene responsible for the resis-
tance was identified as a group 2f, class A, carbapenem-hydrolyz-
ing beta-lactamase, named Klebsiella pneumoniae carbapenemase
1 (KPC-1). Since its discovery, carbapenem resistance caused by
the blaKPC gene has been reported increasingly in K. pneumoniae
isolates, initiallymoving through the northeastern states (3, 4) and
quickly becoming the most frequently found carbapenemase in
the United States (5). The spread of KPC then continued, with
reports fromdifferent countries appearing ceaselessly, to the point
that today this is regarded as a worldwide issue (6).
The blaKPC gene is carried by a plasmid; thus, horizontal trans-
fer between various K. pneumoniae strains, as well as other bacte-
rial species, could be expected and was extensively reported (7–9).
Nevertheless, most of the clinical reports to date have been caused
by K. pneumoniae isolates belonging to clonal complex 258
(CC258) (10). This complex comprises sequence type 258
(ST258) and single-allele mutant STs based on multilocus se-
quence typing (MLST), such as ST11 and ST512. These epidemi-
ological data suggest a dissemination starting from a single ances-
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tor and that CC258 presents a genomic background that is
favorable both to the acquisition of plasmids bearing the blaKPC
gene and to the clonal spread in nosocomial environments. In
2014, Deleo and colleagues (11) presented a phylogenomic study
on 85 K. pneumoniae isolates belonging to CC258, detecting two
subclades and concluding that an 215-kb recombination event
was at the origin of the differentiation between the two. A second
comparative genomic analysis, presented by Chen and colleagues
(12), detected an 1.1-Mb recombination between an ST11 re-
cipient and an ST442 donor as the event that originated the pres-
ent ST258 strain.
Since the first finding of circulation of ESBL-producing K.
pneumoniae in Italy in 1994, a rapid and extensive dissemination
of different types of ESBLs has been reported (13–15). More re-
cently, the first ItalianKPC-positiveK. pneumoniae strain, belong-
ing to ST258, was isolated in a hospital in Florence in 2008 froman
inpatient with a complicated intra-abdominal infection (16).
Since then, the diffusion of carbapenemase-producing K. pneu-
moniae in Italy has been extremely rapid and characterizedmainly
by isolates of CC258 (i.e., ST258 and ST512) (17–19). ST512 in
particular, first reported in Israel in 2006 (20), has been spreading
in southern Europe and South America (11, 19). The sporadic
detection of isolates belonging to other STs (e.g., ST101 and
ST147) also have characterized the epidemiology of KPCK. pneu-
moniae in Italy (19).
The aim of this study was to evaluate the geographic and phy-
logenetic distribution of K. pneumoniae isolates of different anti-
biotypes, both at a national and a global scale. Thus, we sequenced
and analyzed the genomes from 89 K. pneumoniae strains, col-
lected in six Italian hospitals from 2006 to 2013, without any a
priori knowledge of the sequence type.We compared this national
collection to all of the K. pneumoniae genomes available from
worldwide isolations to obtain insights into both the Italian epi-
demiology and the global structure of the species.
MATERIALS AND METHODS
Strain sampling. Eighty-nine nonduplicate K. pneumoniae strains, col-
lected from six different Italian hospitals, were included in this study
without prior knowledge of the sequence type. Thirty-one were KPC pro-
ducers, as demonstrated using phenotypical tests (positivity with disk
diffusion synergy testing using a meropenem disk alone and in combina-
tion with aminophenylboronic acid) (21) and/or genotypical analysis (in-
house methods based on reference 22); 29 were ESBL producers, as dem-
onstrated using the procedure recommended by the CLSI (23), while 29
were susceptible to third-generation cephalosporins and carbapenems.
Throughout this work, we refer to this last group of isolates as susceptible.
Antimicrobial susceptibility testing was performed using a Vitek2 auto-
mated system (bioMérieux), and MICs were interpreted by following the
European Committee on Antimicrobial Susceptibility Testing guidelines
(24). The list of isolates, year, location of isolation, sequence type, and
presence of selected antibiotic resistance genes are reported in Table S1 in
the supplemental material.
Genome sequences.DNA was extracted using a QIAamp DNAmini-
kit (Qiagen) by following the manufacturer’s instructions. Whole
genomic DNA was sequenced using an Illumina Miseq platform with a 2
by 250 paired-end run after Nextera XT paired-end library preparation.
On 24March 2014, sequences of draft and complete genomes of K. pneu-
moniae were retrieved from the NCBI ftp site, while sequencing reads of
the isolates sequenced by Deleo and coworkers (11) were retrieved from
the sequence read archive (SRA) database (accession no. SRP036874).
Genome assembly and retrieval. Sequencing reads from the isolates
obtained in this study were assembled using MIRA 4.0 software (25) with
accurate de novo settings. Assembled genomes are now publicly available
under Bioproject (EMBL project B6543). Reads retrieved from the SRA
database were checked and filtered for sequencing quality using an in-
house script and then assembled using Velvet (26) with a K-mer length of
35 and automatic detection of average expected coverage and low cover-
age threshold.
Resistance profile and MLST determination. The MLST profile was
obtained in silico by searching the characterizing gene variants on each
genome, using an in-house Python script. The antibiotic resistance profile
was determined using a BLAST search on a gene database comprising all
of the most common resistance genes associated with resistance to beta-
lactams, including ESBL- and KPC-producing phenotypes.
Core SNP detection and phylogeny. Single-nucleotide polymor-
phisms (SNPs) were detected using an in-house pipeline based onMauve
software (27), using theNJST258_1 complete genome as a reference. Each
genome was individually aligned to the reference, and alignments were
merged with in-house scripts. Core SNPs were defined as single-nucleo-
tide mutations flanked by identical bases present in all of the analyzed
genomes. The core SNP alignment was used to perform a phylogenetic
analysis using the software RAxML (28)with a generalized time-reversible
(GTR) model and 100 bootstraps. The same phylogenetic approach was
used to perform the analysis on three core SNP sub-data sets (i.e., nonre-
combined regions and two distinct putatively recombined regions).
Recombination.We divided the genome alignment in 5,264 windows
of 1,000 nucleotides (nt) each and calculated core SNP frequency in each
window for each genome, generating a matrix. The software R then was
used to generate a heatmap of SNP frequency. The newly characterized
strain 46AVRwas used as a reference for plotting SNPs, being amember of
the sister group to CC258. In parallel, we created a sub-data set of 174
CC258 genomes and 13 closely relatedK. pneumoniae genomes, removing
genomes of isolates distant from the CC258 clade (n  103) and the
genomes within CC258 that exhibited extremely limited variability (n
29), such as all but one of those obtained from single outbreaks. The
choice of using a relatively large number of non-CC258 genomes (n 13)
was made in order to allow the detection of recombination events com-
mon to the whole clonal complex. We used this sub-data set of core SNPs
in 187 genomes to perform a recombination detection analysis using the
software BRATnextgen (29) with 100-iteration analysis, using 100 repli-
cates for statistical significance.
Analysis of the recombined region.A database was created collecting
protein sequences of factors previously reported to be involved in viru-
lence and antibiotic resistance.We collected sequences from the Compre-
hensive Antibiotic Resistance Database (CARD) (30) and from the Anti-
biotic Resistance Genes Database (ARDB) (31), from proteins involved in
the biosynthesis of lipopolysaccharides (LPS) and polymyxin resistance,
and from the most common virulence factors and siderophores found in
Gram-negative bacteria (obtained from the NCBI site). Finally, we added
to our manually designed database all K. pneumoniae proteins described
as potential virulence or resistance factors in the work by Lery and col-
leagues (32). Gene sequences present in the novel putative recombined
region were extracted from the genome of strain NJST258_1 using an
in-house Python script. Correspondence between proteins in our data-
base and genes in the recombined region was tested using a TBLASTN
search, selecting genes covering at least 75%of the database sequence with
a minimum of 75% identity. Results then were manually checked (see
Table S2 in the supplemental material for a complete list).
Molecular clock. We created a sub-data set of 174 CC258 genomes
and 3 closely relatedK. pneumoniae genomes (used as outgroups), remov-
ing genomes of isolates distant from the CC258 clade (n  113) and the
genomes within CC258 that exhibited extremely limited variability (n
29), such as all but one of those obtained from single outbreaks. We used
the software BEAST (33) on the core SNP alignment of the 177-genome
sub-data set after removing SNPs located in the potentially recombined
regions. BEAST parameters used were the following: uncorrelated log-
normal relaxed clock with the GTRmodel, with no correction for site rate
Gaiarsa et al.
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heterogeneity according to analyses performed in similar scenarios (34).
The analysis was run for 1,000,000,000 steps, and at every 10,000 steps
samples were taken.We discarded 250,000,000 steps as burn-in. The pro-
gramTRACER (http://beast.bio.ed.ac.uk/tracer/) was used to evaluate the
convergence of the analysis.
RESULTS
Sampling and genome sequencing. Eighty-nine K. pneumoniae
strains were collected in six Italian hospitals, chosen based on
antibiotypes regardless of sequence type, which was determined
only afterwards. The data set was composed of 31 KPC producers,
29 ESBL producers, and 29 strains susceptible to carbapenems and
third-generation cephalosporins, here referred to as susceptible.
The genome of each of the 89 isolates was sequenced and assem-
bled (average genome size, 5,551,959 nt; average N50, 154,414 nt;
average coverage, 76.46). All of the available K. pneumoniae ge-
nome sequences and reads then were retrieved from the databases
(n  230) to create a global data set of 319 K. pneumoniae ge-
nomes. All genomes in the data set were screened for genes re-
sponsible for KPC and beta-lactam resistance phenotypes, as well
as for all MLST genes. A total of 55 different MLST profiles were
detected, eight of which were novel; thus, they were submitted to
the curators of theK. pneumoniaeMLSTdatabase (35). Each of the
eight new profiles was represented by a single newly sequenced
Italian isolate (7 susceptible, 1 ESBL producer). Two of these iso-
lates also presented a single novel allele, one for the gene rpoB and
one for the gene infB. See Table S1 in the supplemental material
for a list of all of the isolates sequenced in this study and theirmain
characteristics.
Global SNP phylogeny.We used a maximum likelihood phy-
logenomic approach based on core SNPs to elucidate the relation-
ships within the global genome data set comprising the newly
sequenced isolates and the K. pneumoniae genome sequences
available in the database. The presence of antibiotic resistance
genes was mapped on the resulting phylogenetic tree, obtained
from an alignment of 94,812 core SNPs (Fig. 1). This revealed that
97% of all KPC K. pneumoniae strains sequenced to date, regard-
less of the location of isolation, belong to a well-supported clade,
corresponding to the complex CC258. On the other hand, the
phylogenomic analysis showed that the isolates encoding com-
mon beta-lactam resistance genes (blaSHV family, blaTEM family,
blaOXA family, and blaCTX-M family) are widespread along the tree
and belong to various STs (both inside and outside CC258), with
no sign of clustering. In fact, the 141 isolates encoding blaTEM
belong to 24 different STs, the 26 isolates encoding blaOXA belong
to 11 different STs, and the 37 isolates encoding blaCTX-M belong
to 16 different STs.
FIG 1 Maximum likelihood phylogeny ofKlebsiella pneumoniae, based on 319 genomes. The phylogeny was reconstructed starting from an alignment of 94,812
core SNPs, using the software RAxMLwith a generalized time-reversible (GTR)model and 100 bootstraps, which are not shown for the sake of figure clarity. (A)
Circular representation of the phylogeny, obtained using iTOL (itol.embl.de), ignoring branch length. Color circles indicate, from the innermost to the
outermost, presence/absence of KPC variants, geographic location in terms of continents, ST based on multilocus sequence typing, and presence in the genome
of genes from four beta-lactamase families. The red arrow indicates the origin of the clonal complex 258 clade. (B) Unrooted representation of the phylogeny
showing the branch lengths, highlighting the genetic uniformity of clonal complex 258.
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Phylogeny excluding potentially recombined regions. In a
recent work by Castillo-Ramirez and coworkers (34), high-den-
sity SNPs clusters with a low ratio of nonsynonymous to synony-
mous evolutionary changes (dN/dS) in closely related bacterial
genomes were suggested to be indicators of recombination events.
Thus, we evaluated the distribution of SNPs on the genome data
set, detecting a highly uneven distribution in the genomes of
CC258 isolates, as most core SNPs clustered into two main re-
gions. The first region is located between positions 1,675,550 and
2,740,033, while the second comprises the origin of replication
and spans from 4,554,906 to 629,621 in strain NJST258_1 (Fig. 2)
(for the distribution of core SNPs on the whole data set of 319
genomes, see Fig. S1 in the supplemental material). To further
analyze the possible presence of recombination events in CC258,
we used the software BRATnextgen (29), specifically intended for
this purpose, on a reduced data set of 187 genomes of CC258 and
closely related strains. This analysis (see Fig. S2) confirmed the
presence of the two main recombination events, additionally in-
dicating in what position of the phylogeny they could have oc-
curred. The first event was placed between the entire CC258 clade
and the non-KPC external isolates of different STs, while the sec-
ond was between the outermost strains of ST11 and the inner
CC258 clade. Details on these recombined regions are presented
in the following paragraph.
We removed the two putative recombined regions from the
core SNPs data set of 319 K. pneumoniae genomes and performed
a phylogenetic analysis on the remaining 55,368 core SNPs. The
resulting tree (see Fig. S3 in the supplemental material) is largely
consistent with the one generated from the initial data set, con-
firming the widespread distribution of susceptible and ESBL iso-
lates and the presence of the highly supported KPC CC258 clade.
Indeed, both the analysis on all core SNPs and the one performed
by removing recombining sites agree in clustering 97% of all KPC
K. pneumoniae isolates sequenced in a well-supported clade (Fig.
1; also see Fig. S3). This monophyletic clade comprises 203 strains
from Asia, Europe, Oceania, and North and South America, with
isolation dates ranging from 2002 to 2013; 193 of these (95%)
present the blaKPC gene.Most isolates of this clade belong to ST258
(n  167), but 4 other sequence types are present (i.e., ST11,
SST379, ST418, and ST512), all single-nucleotide variants of
ST258; thus, they belong to CC258. The second most common
sequence type in the CC258 clade is 512, represented by 28 isolates
that form a single monophyletic subgroup, located within the
ST258 diversity. Interestingly, 24 of these 28 have been isolated in
Italy, mostly in this study (n 19) but also in previous works (18,
36). Within the CC258 clade, two main highly supported distinct
subclades are detectable, comprising the vast majority of the ge-
nomes. Three additional CC258 genomes are located in the tree as
FIG 2 Uneven clustering of core SNPs in the clonal complex 258 clade. The phylogenetic reconstruction of the 206 representatives of the clonal complex 258
clade is shown on the left, while the core SNP frequency is shown on the right in shades of red, representing the number of core SNPs per 1,000-bp window for
each genome. Detected recombinations are indicated at the top of the figure, and main clades of the clonal complex are indicated on the right side of the figure.
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sister groups of the two main clades, and all are representatives of
ST11, again a single-nucleotide variation of ST258. The existence
of the two main CC258 subclades was reported previously, and a
single recombination event was proposed to be the cause of the
differentiation between the two (11), while a subsequent work
suggested multiple recombination events (37).
Analysis of recombined regions. As described above, the SNP
clustering analysis detected high SNP concentrations in two large
genomic regions (Fig. 2). The smaller of the two is highly congru-
ent with the 1.1-Mb recombination found by Chen and col-
leagues (12), which represents the major evolutive change be-
tween the members of ST11 and those in the 2 main subclades of
the CC258 clade. Chen and colleagues found this region to be
most similar to the corresponding region of isolate Kp13 of ST442
and suggested a recombination event, with the donor strain being
a close relative of Kp13. Thus, we investigated whether a recom-
bination event is at the origin of the second, newly detected, highly
mutated genomic region, located from positions 4,554,906 to
629,621. We performed a phylogenetic analysis, including all of
the 319 K. pneumoniae genomes examined in this work, on the
core SNPs located in this region and in parallel on the core SNPs
located in the 1.1-Mb region. The phylogenetic analysis of the
novel1.3-Mb region (see Fig. S4 in the supplemental material)
confirms the recombination hypothesis, as the topology of the
resulting tree clearly shows that Italian isolate 67BO, of the newly
described ST1628, is the sister taxon to the entire CC258 clade,
suggesting that the donor was related to this isolate. The phy-
logenetic tree obtained from the 1.1-Mb recombined region
(see Fig. S5) confirms the published results, clustering the do-
nor Kp13 as a sister taxon of the CC258 clade, with the exclu-
sion of the outermost ST11 isolates. Thus, we propose an up-
dated scenario in which a first recombination event gave origin
to the first CC258 strains (represented by ST11), a second re-
combination subsequently originated ST258, and a third,
smaller recombination initiated the split between the two main
ST258 subclades (Fig. 3).
In order to investigate the potential effect of the newly discov-
ered recombination on the phenotype of the acceptor CC258, the
presence of genes possibly related to antibiotic resistance and vir-
ulence was investigated in the corresponding region of the ge-
nome of strain NJST258_1, using a specifically designed database
(seeMaterials andMethods). Interestingly, 51 geneswere detected
in the region (see Table S2 in the supplementalmaterial), grouped
in three main categories: LPS modification (such as the waa
operon), bacterial efflux transporters (i.e., efflux pumps and per-
meases), and regulators (e.g., ompR-envZ operon) (seeDiscussion
for an analysis of the detected genes).
Molecular clock. In order to date the origin of the CC258 clade
and its subclades, we performed a molecular clock analysis using
the software BEAST (33).We produced a reduced data set of 3,615
core SNPs present in a selected subset of taxa (174 CC258 and
three closely related non-KPC K. pneumoniae genomes used as
outgroups), derived from the previously filtered data set, in which
the potentially recombined regions of the genome were excluded
(Fig. 4). Compared with the dates indicated in published reports,
our estimations appear to be fairly accurate. For example, the
molecular clock analysis dates the appearance of ST512 to 2007,
close to the first report in Israel, i.e., 2006 (20). Additionally, the
molecular clock analysis dates the radiation of American and Eu-
ropean ST258 isolates to 1997, a time point coherent with the first
report of KPC-bearing K. pneumoniae, i.e., 1996 (2). Thus, our
calibration of the evolutionary rate, superimposed on the phylo-
genetic tree (Fig. 4), could be used to infer unavailable dates on the
global pandemic of CC258K. pneumoniae. See Discussion for fur-
ther discussion of the estimated dates.
Italian strains. The structure of the phylogenomic tree allows
us to depict the scenario of the epidemiology of K. pneumoniae in
Italy (Fig. 1 and 4). While susceptible and ESBL Italian strains are
homogeneously distributed on the tree and belong to a number of
different STs (24 and 15, respectively), all of the KPC strains se-
quenced in Italy belong to CC258, indicating a strong epidemio-
logical prevalence of this clonal complex in the Italian hospitals.
Within CC258, Italian isolates are well clustered in four mono-
phyla, three composed mostly of isolates sequenced in this study
and one encompassing two isolates from a previous study (38). Of
the four Italian CC258 monophyla, the one including the most
isolates is composed solely of ST512 (n  24), confirming the
multiple reports that indicate this ST as being of great epidemio-
logical importance, at least in this country. Our phylogenetic anal-
ysis clearly indicates that this ST512monophylum is foundwithin
the diversity of ST258.
FIG 3 Hypothesis of recombinations occurring in the clonal complex 258 clade. Schematic representation based on the results of the analyses presented. Main
nodes of interest are shown, highlighting the hypothesized pattern of three recombination events leading to the current state of clonal complex 258. Dates are
inferred based on the molecular clock analysis depicted in Fig. 4.
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DISCUSSION
Klebsiella pneumoniae in Italy.We sequenced the genomes of 89
K. pneumoniae strains isolated in Italy, among them 31 KPC pro-
ducers, 29 ESBL producers, and 29 strains susceptible to beta-
lactams and carbapenems. Based on our phylogenomic analysis,
the 29 genomes from susceptibleK. pneumoniae strains isolated in
Italy are scattered along the tree, showing no evident sign of clus-
terization. The sequencing of these isolates allowed us to expand
the known diversity of the K. pneumoniae species, detecting seven
novel MLST profiles and contributing to the overall robustness of
current and future phylogenetic analyses. The genomes obtained
from 29 ESBL isolates also show a considerable diversity, as they
are distributed on the phylogenetic tree and belong to 15 different
STs, among them a newly found ST.
Regarding KPC isolates, all Italian sequenced strains are found
in CC258. Since no a priori selection of STs was performed, this
result indicates a strong prevalence of CC258 among KPC K.
pneumoniae isolates in Italy, even though isolates from different
STs have been reported previously by nongenomic studies (e.g.,
reference 19), and a wider genomic sampling surely would allow
us to obtain genomes of KPC isolates belonging to other STs. The
genomes of KPC-producing K. pneumoniae strains isolated in It-
aly cluster in four monophyletic groups. If we consider that the
first reported case of KPC in Italy occurred in 2008, we can use the
dates obtained from the molecular clock to conclude that these
monophyletic groups represent four different entrances of KPCK.
pneumoniae in Italy (Fig. 4). This indicates that KPC strains can
move effectively among different countries and continents, and
that the current Italian scenario of widespread KPC resistance has
been caused by multiple overlapping outbreaks. Additional sam-
pling from Italian CC258 isolates could either confirm these re-
sults or detect novel monophyla, possibly discovering additional
entrance events.
Among the four Italian CC258 monophyla, one is composed
entirely of isolates of ST512. This KPC sequence type was first
reported in Israel in 2006 (20) but has been spreading since then,
mostly in Italy and South America (11, 17). In accordance with
these reports, the four available ST512 genomes from South
American isolates cluster in our phylogeny as a sister group of the
Italian ST512 clade (Fig. 1 and 4). The molecular clock analysis
dates the common ancestor of all members of ST512 to 2007, in
relative agreement with the first report of this ST, i.e., 2006 (20).
Considering that this ST is known to be a single-nucleotide variant
of ST258, these results indicate that a mutational event occurred
around 2006, giving rise to this sequence type, that then spread to
Israel, South America, and Italy. Genome sequencing of isolates of
this ST from Israel, currently unavailable, could allow us to per-
form phylogenetic analyses aimed at better understanding the
geographical and temporal origin of the ST512 clade.
Origin of the CC258 clade. Our phylogenomic analysis, cou-
pled with the detection of recombination events and with themo-
lecular clock analysis, allow us to update the hypothesis regarding
the origin and evolution of CC258, the most widespread bearer of
KPC resistance worldwide (Fig. 3). We postulate a first recombi-
nation event that occurred before 1985 between a donor similar to
ST1628 and a receiver, an ancestor of ST11. This event, which
transferred a region of1.3 Mb to the current ST11, gave rise to
the basal lineage of CC258. Since only three genomes of ST11
currently are available, all isolated fromAsian patients, the current
phylogeny suggests that this first recombination event occurred
on theAsian continent.However, additional genome sequences of
ST11 from different geographic locations are necessary to support
or falsify this hypothesis. Our molecular clock analysis also can be
useful to date the two subsequent, previously reported (11, 12)
recombination events. The second recombination event, con-
firmed by our phylogenies, gave rise to ST258, having as a recipi-
FIG 4 Estimation of divergence times in clonal complex 258. A schematic version of the time-scaled phylogeny was obtained using BEAST software with an
uncorrelated log-normal relaxed clock andGTRmodel with no correction for site rate heterogeneity. The analysis was run for 1,000,000,000 steps, with sampling
every 10,000 steps and 25% burn-in. The Italian monophyla are highlighted in blue, while the sequence type 11 (ST11) Asian clade is highlighted in green. All of
the phylawith no indication of ST are comprisedmainly of isolates of ST258. The dates indicated in the figure, for selected branches andnodes, were inferred from
the analysis described above; for a comparison with the dates of isolation of strains, see Discussion.
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ent ST11 and a donor similar to ST442 (12). Our molecular clock
analysis dates this event to between 1985 and 1997. Considering
that all of the known genomic CC258 diversity from the American
and European continents is included within the subclade that
originated in 1997 (Fig. 4), this second event could have been
pivotal in the subsequent pandemic of KPC-bearing CC258. Fi-
nally, we can date the third smaller recombination event, the one
that gave origin to the differentiation between the two main
CC258 subclades (11), to between 1999 and 2001. Thus, we can
hypothesize that these three events have produced a genomic
background apt to bear and diffuse KPCplasmids, contributing to
the success of the KPC pandemic.
The proposed scenario suggests that the genomic diversity of
the whole K. pneumoniae species constitutes a reservoir of genetic
variability capable of recombination events of large portions of the
genome, with subsequent generation of novel variants. In this sce-
nario, we hypothesize that large genomic recombinations are at
the basis of important phenotypic/functional changes that, to-
gether with the acquisition and diffusion of plasmids bearing an-
tibiotic resistance genes, have led to the current global epidemic.
This hypothesis is supported by the multiple detected recombina-
tion events, as well as by the limited number of SNPs identified
outside the recombined regions (a total of 1,086 core SNPs in the
206 analyzed CC258 genomes), and finally by the current impos-
sibility to phenotypically differentiate the isolates of subclade
ST512 from those of ST258. An alternative hypothesis is that the
main reason for the diffusion of CC258 is simply the acquisition of
the resistance to carbapenemic antibiotics, and that the genomic
variations, whether they are recombinations or point mutations,
do not provide a specific fitness benefit but are merely an example
of genetic hitchhiking.
In order to investigate the importance of the recombination
event described in this work, the gene content of the 1.3-Mb
region was analyzed. Fifty-one genes in this genomic context were
found to be potentially related to virulence or antibiotic resistance
(see Table S2 in the supplemental material). The presence of LPS
synthesis genes is worth a mention because of the multiple link-
ages between the outer membrane and virulence (39). Genes of
the operonwaa (also known as rfa) are responsible for the biogen-
esis of the core LPS, while genes of the family arn control the
modifications of lipid A. Modifications in membrane composi-
tion can lead to changes in surface charge and interfere with the
activity of antibiotics that act on LPS, such as polymyxins and
novobiocin (40). Moreover, the presence of mla genes in the re-
combined region is worth being highlighted. These genes are pre-
sumed to maintain lipid asymmetry in the Gram-negative outer
membrane, as they transport phospholipids to the inner side of
the membrane. mla genes were reported as virulence factors in
Escherichia coli and in other Gram-negative bacteria, as mutations
in these genes can lead to a change in the permeability of the outer
membrane and to a subsequent variation in virulence (41). The
presence of fumarate reductase genes of the family fmr in the re-
combined region suggests a link with the variation of virulence of
CC258. In fact, fumarate reductase is a virulence determinant in
Helicobacter pylori, Mycobacterium tuberculosis, Actinobacillus
pleuropneumoniae, and Salmonella enterica, as mutants of these
genes show variations in virulence (32). Finally, the ompR-envZ
operon, present in the recombined region, is a two-component
system that acts as a transcription regulator, affecting the expres-
sion of the genes ompF and ompC (42).Mutations in the ompR and
envZ genes have been shown to reduce the expression of outer
membrane porins OmpF and OmpC (43). This in turn can have
drastic effects on both the virulence and antibiotic resistance of
mutant strains. It has been reported in particular thatOmpRmu-
tations can lead to reduced susceptibility to carbapenemic antibi-
otics in Enterobacteriaceae (44).
Further functional investigations aimed at unveiling the rea-
sons for the success of the CC258 clade, possibly focusing on the
detected recombinant regions, would greatly improve our under-
standing of the K. pneumoniae pandemic and would provide im-
portant tools in the fight against KPC-producing strains. Finally,
our conclusions should lead to additional studies focused on the
recombination potential of other STs of K. pneumoniae. If this
capacity were found to be widespread, we should be aware that
future recombination events could lead to the diffusion of novel
epidemic clones.
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